30 studies found for:    "Erythema multiforme"
Show Display Options
Rank Status Study
1 Completed
Has Results
Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
Condition: Plaque Psoriasis
Intervention: Drug: Clobex Spray
2 Not yet recruiting A Randomized Two Arm Phase II Trial of Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC
Condition: Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Pembrolizumab;   Radiation: Single Fraction Radiation Therapy
3 Not yet recruiting Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
Condition: Toxic Epidermal Necrolysis
Interventions: Drug: Isotretinoin;   Other: Placebo
4 Not yet recruiting G-CSF in the Treatment of Toxic Epidermal Necrolysis
Condition: Stevens - Johnson Syndrome
Interventions: Drug: recombinant granulocyte - colony stimulating factor;   Drug: NaCl 0.9%
5 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
Intervention:
6 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
7 Available Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
Conditions: Limbal Stem Cell Deficiency;   Stevens-johnson Syndrome;   Ocular Cicatricial Pemphigoid;   Chemical Burn
Intervention: Biological: cultivated oral mucosal epithelial sheet transplantation
8 Enrolling by invitation Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis (Lyell) Syndrome;   Mucous Membrane Pemphigoid
Intervention: Drug: topical infliximab
9 Unknown  Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
Conditions: Toxic Epidermal Necrolysis;   Stevens-Johnson Syndrome
Intervention: Drug: Palifermin
10 Completed Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis
Intervention: Drug: Intravenous immunoglobulin
11 Unknown  Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin
12 Completed Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
Condition: Stevens-Johnson Syndrome
Intervention: Drug: 0.05%cyclosporin eye drop
13 Withdrawn Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
14 Enrolling by invitation Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.
Conditions: Symblepharon;   Dry Eye;   Ocular Surface Disease;   Transplantation
Intervention: Procedure: Salivary Gland and Labial Mucous Membrane Transplantation
15 Unknown  Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye
Condition: Stevens-Johnson Syndrome
Intervention:
16 Completed Stevens-Johnson Syndrome Antimicrobial
Condition: Stevens-Johnson Syndrome
Intervention:
17 Withdrawn Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Remicaide (infliximab)
18 Completed Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
Conditions: Pterygium;   Ocular Surface Disease;   Stevens Johnson Syndrome;   Chemical Injury
Intervention: Procedure: Cultivated conjunctival transplantation
19 Completed Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Drug: liposomal lurtotecan
20 Active, not recruiting Resolute Integrity US Extended Length Sub-Study(RI-US XL)
Condition: Coronary Artery Disease
Intervention: Device: Resolute Integrity Stent

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years